Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Influenza
- Sponsor
- Emory University
- Enrollment
- 330
- Locations
- 11
- Primary Endpoint
- Receipt of influenza vaccine during pregnancy
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The primary research aim of this project is to test the effectiveness of a comprehensive, evidence-based vaccine promotion package implemented in the obstetric setting on increasing the likelihood that a pregnant woman in Georgia will receive an influenza and/or pertussis vaccine.
Detailed Description
The primary research aim of this project is to test the effectiveness of a comprehensive, evidence-based vaccine promotion package implemented in the obstetric setting on increasing the likelihood that a pregnant woman in Georgia will receive an influenza vaccine and/or Tdap vaccine before delivery. A secondary research aim assesses whether the comprehensive package improves maternal knowledge, attitudes, and beliefs regarding maternal and infant vaccination. The intervention package will include evidence-based components aimed at the practice-level, provider-level, and patient level and will be tested through a cluster-randomized trial design. The primary outcome measure is influenza vaccine receipt during pregnancy. The secondary outcomes include 1) receipt of pertussis (Tdap) vaccination during pregnancy, and 2) changes in maternal knowledge, attitudes and beliefs regarding maternal and infant vaccination. The primary hypothesis is that implementation of a comprehensive vaccine promotion package in the obstetric setting will increase the likelihood that a pregnant woman receives an influenza and/or pertussis vaccination.
Investigators
Saad B. Omer, PhD
Assistant Professor Global Health, Epidemiology, and Pediatrics, Emory University, Schools of Public Health & Medicine & Emory Vaccine Center
Emory University
Eligibility Criteria
Inclusion Criteria
- •Between the ages of 18 - 50
- •Currently pregnant
- •Unvaccinated with 2012 - 2013 seasonal influenza vaccine
- •Unvaccinated with Tdap vaccine during current pregnancy
Exclusion Criteria
- •Under 18 years of age or over 50
- •Not currently pregnant
- •Previous receipt of 2012 - 2013 seasonal influenza vaccine
- •Previous receipt of Tdap vaccine during current pregnancy
- •Does not speak English
Outcomes
Primary Outcomes
Receipt of influenza vaccine during pregnancy
Time Frame: Participants will be followed for the remaining duration of their pregnancy, which will range from approximately 2 weeks to 7 months depending upon their gestation at enrollment.
Our primary outcome is receipt of a 2012 - 2013 seasonal influenza vaccine during a participant's current pregnancy, before she delivers her child(ren).
Secondary Outcomes
- Receipt of Tdap vaccine during pregnancy(Participants will be followed for the remaining duration of their pregnancy, which will range from approximately 2 weeks to 7 months depending upon their gestation at enrollment.)